Table 1 The baseline characteristics in T2DM patients with and without cognitive impairment
From: The association between blood lipids and cognitive impairment in type 2 diabetes mellitus
Patients with cognitive impairment | Patients without cognitive impairment | p value | |
|---|---|---|---|
N = 94 | N = 242 | ||
Male (n, %) | 39 (41.5) | 165 (68.2) | < 0.001 |
Age (years) | 67 (62–73) | 60 (52–66) | < 0.001 |
Body mass index (kg/m2) | 24.3 (22.5–26.5) | 24.9 (22.9–27.7) | 0.166 |
Hypertension history (n, %) | 67 (71.3) | 151 (62.4) | 0.126 |
Smoking history (n, %) | 24 (25.5) | 68 (28.1) | 0.636 |
Drink history (n, %) | 11 (11.7) | 28 (11.6) | 0.973 |
Education years | 11 (8–14) | 15 (11–15) | < 0.001 |
MMSE score | 23 (21–24) | 29 (28–30) | < 0.001 |
MoCA score | 24 (21–25) | 29 (28–30) | < 0.001 |
High-density lipoprotein cholesterol (mmol/L) | 1.12 (1.00–1.43) | 1.17 (1.01–1.36) | 0.836 |
Low-density lipoprotein cholesterol (mmol/L) | 2.32 (1.69–2.92) | 2.39 (1.82–3.00) | 0.275 |
Triglyceride (mmol/L) | 1.24 (0.91–1.94) | 1.41 (0.96–2.13) | 0.288 |
Total cholesterol (mmol/L) | 4.13 (3.45–4.91) | 4.24 (3.33–5.07) | 0.376 |
Apolipoprotein A1 (g/L) | 1.15 ± 0.21 | 1.09 ± 0.20 | 0.017 |
Apolipoprotein B (g/L) | 0.82 (0.68–0.96) | 0.85 (0.69–1.02) | 0.342 |
Apolipoprotein A1/Apolipoprotein B ratio | 1.40 (1.14–1.74) | 1.28 (1.04–1.65) | 0.070 |
Uric acid (µmol/L) | 283 (235–353) | 300 (228–373) | 0.586 |
Creatinine (µmol/L) | 64 (54–79) | 65 (55–80) | 0.538 |
Glycated hemoglobin (%) | 9.50 (8.20–10.56) | 8.11 (6.80–9.90) | < 0.001 |